Accovion names a new CEO; Cromos reaches into Israel;

> Germany's Accovion has named Andree Beckerling as its next CEO, replacing Martin Schröder, who has helmed the company since it spun off of Aventis 8 years ago. News

> European CRO Cromos Pharma has expanded its footprint to include Israel, where it believes the market for clinical research is growing. Story

> WuXi PharmaTech ($WX) is poised to outperform its financial guidance for 2013, the company said, expecting to beat its earnings projections when it releases full-year financials in March. Article

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.